Cargando…
Serous macular detachment, yellow macular deposits, and prominent middle limiting membrane in multiple myeloma
Bone marrow-derived multiple myeloma is a type of plasma cell tumor that may be associated with ocular complications. A 52-year-old male patient was admitted to our eye clinic with the complaint of sudden visual loss and a visual acuity of 20/50 in the right eye and 20/800 in the left eye. Fundus ex...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425312/ https://www.ncbi.nlm.nih.gov/pubmed/25995641 http://dx.doi.org/10.2147/TCRM.S79232 |
_version_ | 1782370469043765248 |
---|---|
author | Dogan, Berna Erol, Muhammet Kazim Toslak, Devrim Coban, Deniz Turgut Bulut, Mehmet Cengiz, Ayse Sari, Esin Sogutlu |
author_facet | Dogan, Berna Erol, Muhammet Kazim Toslak, Devrim Coban, Deniz Turgut Bulut, Mehmet Cengiz, Ayse Sari, Esin Sogutlu |
author_sort | Dogan, Berna |
collection | PubMed |
description | Bone marrow-derived multiple myeloma is a type of plasma cell tumor that may be associated with ocular complications. A 52-year-old male patient was admitted to our eye clinic with the complaint of sudden visual loss and a visual acuity of 20/50 in the right eye and 20/800 in the left eye. Fundus examination revealed common flame-shaped hemorrhages, venous dilatation and tortuosity, Roth spots, serous macular detachment, and yellow macular deposits in both eyes. Evaluation with fundus fluorescein angiography, fundus autofluorescence, and spectral-domain optical coherence tomography resulted in suspicion of hyperviscosity retinopathy and referral to the hematology clinic. After hematology consultation confirmed a diagnosis of multiple myeloma, chemotherapy and plasmapheresis were initiated. Four months after presentation, best-corrected visual acuity was 20/20 in both eyes and improvement in hyperviscosity retinopathy, serous macular detachment, and yellow macular deposits was observed. |
format | Online Article Text |
id | pubmed-4425312 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-44253122015-05-20 Serous macular detachment, yellow macular deposits, and prominent middle limiting membrane in multiple myeloma Dogan, Berna Erol, Muhammet Kazim Toslak, Devrim Coban, Deniz Turgut Bulut, Mehmet Cengiz, Ayse Sari, Esin Sogutlu Ther Clin Risk Manag Case Report Bone marrow-derived multiple myeloma is a type of plasma cell tumor that may be associated with ocular complications. A 52-year-old male patient was admitted to our eye clinic with the complaint of sudden visual loss and a visual acuity of 20/50 in the right eye and 20/800 in the left eye. Fundus examination revealed common flame-shaped hemorrhages, venous dilatation and tortuosity, Roth spots, serous macular detachment, and yellow macular deposits in both eyes. Evaluation with fundus fluorescein angiography, fundus autofluorescence, and spectral-domain optical coherence tomography resulted in suspicion of hyperviscosity retinopathy and referral to the hematology clinic. After hematology consultation confirmed a diagnosis of multiple myeloma, chemotherapy and plasmapheresis were initiated. Four months after presentation, best-corrected visual acuity was 20/20 in both eyes and improvement in hyperviscosity retinopathy, serous macular detachment, and yellow macular deposits was observed. Dove Medical Press 2015-04-30 /pmc/articles/PMC4425312/ /pubmed/25995641 http://dx.doi.org/10.2147/TCRM.S79232 Text en © 2015 Dogan et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Case Report Dogan, Berna Erol, Muhammet Kazim Toslak, Devrim Coban, Deniz Turgut Bulut, Mehmet Cengiz, Ayse Sari, Esin Sogutlu Serous macular detachment, yellow macular deposits, and prominent middle limiting membrane in multiple myeloma |
title | Serous macular detachment, yellow macular deposits, and prominent middle limiting membrane in multiple myeloma |
title_full | Serous macular detachment, yellow macular deposits, and prominent middle limiting membrane in multiple myeloma |
title_fullStr | Serous macular detachment, yellow macular deposits, and prominent middle limiting membrane in multiple myeloma |
title_full_unstemmed | Serous macular detachment, yellow macular deposits, and prominent middle limiting membrane in multiple myeloma |
title_short | Serous macular detachment, yellow macular deposits, and prominent middle limiting membrane in multiple myeloma |
title_sort | serous macular detachment, yellow macular deposits, and prominent middle limiting membrane in multiple myeloma |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425312/ https://www.ncbi.nlm.nih.gov/pubmed/25995641 http://dx.doi.org/10.2147/TCRM.S79232 |
work_keys_str_mv | AT doganberna serousmaculardetachmentyellowmaculardepositsandprominentmiddlelimitingmembraneinmultiplemyeloma AT erolmuhammetkazim serousmaculardetachmentyellowmaculardepositsandprominentmiddlelimitingmembraneinmultiplemyeloma AT toslakdevrim serousmaculardetachmentyellowmaculardepositsandprominentmiddlelimitingmembraneinmultiplemyeloma AT cobandenizturgut serousmaculardetachmentyellowmaculardepositsandprominentmiddlelimitingmembraneinmultiplemyeloma AT bulutmehmet serousmaculardetachmentyellowmaculardepositsandprominentmiddlelimitingmembraneinmultiplemyeloma AT cengizayse serousmaculardetachmentyellowmaculardepositsandprominentmiddlelimitingmembraneinmultiplemyeloma AT sariesinsogutlu serousmaculardetachmentyellowmaculardepositsandprominentmiddlelimitingmembraneinmultiplemyeloma |